维普中文期刊产品整合服务
1篇 您的检索式:作者名="Mohammad Abdalgaber"
    题名 作者 年代 出处 被引量
1Hemostatic system and COVID-19 crosstalk:A review of the available evidence显示文摘Since the discovery of severe acute respiratory syndrome coronavirus 2(SARSCoV-2)and its resultant coronavirus disease 2019(COVID-19)pandemic,respiratory manifestations have been the mainstay of clinical diagnosis,laboratory evaluations,and radiological investigations.As time passed,other pathological aspects of SARS-CoV-2 have been revealed.Various hemostatic abnormalities have been reported since the rise of the pandemic,which was sometimes superficial,transient,or fatal.Mild thrombocytopenia,thrombocytosis,venous,arterial thromboembolism,and disseminated intravascular coagulation are among the many hemostatic events associated with COVID-19.Venous thromboembolism necessitating therapeutic doses of anticoagulants is more frequently seen in severe cases of COVID-19,especially in patients admitted to intensive care units.Hemorrhagic complications rarely arise in COVID-19 patients either due to a hemostatic imbalance resulting from severe disease or as a complication of over anticoagulation.Although the pathogenesis of coagulation disturbance in SARS-CoV-2 infection is not yet understood,professional societies recommend prophylactic antithrombotic therapy in severe cases,especially in the presence of abnormal coagulation indices.The review article discusses the various available evidence on coagulation disorders,management strategies,outcomes,and prognosis associated with COVID-19 coagulopathy,which raises awareness about the importance of anticoagulation therapy for COVID-19 patients to guard against possible thromboembolic events.Mohamed-Naguib Wifi Mohamed Abdelkader Morad Reem El Sheemy Nermeen Abdeen Shimaa Afify Mohammad Abdalgaber Abeer Abdellatef Mariam Zaghloul Mohamed Alboraie Mohamed El-Kassas 2022World Journal of Methodology2022,12,5:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费